[go: up one dir, main page]

AU2003266585A1 - Novel mammal-origin protein negatively regulating the expression of antigen presentation-associated molecule such as b7-2 molecule or mhc class ii molecule on cell surface and utilization of the same - Google Patents

Novel mammal-origin protein negatively regulating the expression of antigen presentation-associated molecule such as b7-2 molecule or mhc class ii molecule on cell surface and utilization of the same

Info

Publication number
AU2003266585A1
AU2003266585A1 AU2003266585A AU2003266585A AU2003266585A1 AU 2003266585 A1 AU2003266585 A1 AU 2003266585A1 AU 2003266585 A AU2003266585 A AU 2003266585A AU 2003266585 A AU2003266585 A AU 2003266585A AU 2003266585 A1 AU2003266585 A1 AU 2003266585A1
Authority
AU
Australia
Prior art keywords
molecule
utilization
expression
cell surface
mhc class
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003266585A
Inventor
Satoshi Ishido
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New Industry Research Organization NIRO
Original Assignee
New Industry Research Organization NIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Industry Research Organization NIRO filed Critical New Industry Research Organization NIRO
Publication of AU2003266585A1 publication Critical patent/AU2003266585A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2003266585A 2002-12-27 2003-09-24 Novel mammal-origin protein negatively regulating the expression of antigen presentation-associated molecule such as b7-2 molecule or mhc class ii molecule on cell surface and utilization of the same Abandoned AU2003266585A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002381913 2002-12-27
JP2002-381913 2002-12-27
PCT/JP2003/012173 WO2004061106A1 (en) 2002-12-27 2003-09-24 Novel mammal-origin protein negatively regulating the expression of antigen presentation-associated molecule such as b7-2 molecule or mhc class ii molecule on cell surface and utilization of the same

Publications (1)

Publication Number Publication Date
AU2003266585A1 true AU2003266585A1 (en) 2004-07-29

Family

ID=32708518

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003266585A Abandoned AU2003266585A1 (en) 2002-12-27 2003-09-24 Novel mammal-origin protein negatively regulating the expression of antigen presentation-associated molecule such as b7-2 molecule or mhc class ii molecule on cell surface and utilization of the same

Country Status (3)

Country Link
JP (1) JP4515266B2 (en)
AU (1) AU2003266585A1 (en)
WO (1) WO2004061106A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111781377B (en) * 2020-07-13 2021-12-17 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） Method for identifying the chance of viral infection in mammalian cells

Also Published As

Publication number Publication date
JP4515266B2 (en) 2010-07-28
WO2004061106A1 (en) 2004-07-22
JPWO2004061106A1 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
AU2003293171A1 (en) Cross-linked silicone gels; products containing the same; and methods of manufacture thereof
AU2003281712A1 (en) Rotation system with three degree of freedom and application of the same
AU2002246422A1 (en) Cell culture plate and system using the same
AU2002365228A1 (en) Antigen panels and methods of using the same
AU2003234198A1 (en) Novel genes, compositions, and methods for modulating the unfolded protein response
AU2003304180A1 (en) Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses
AU2003224313A1 (en) Mycobacterial antigens and uses thereof
AU2003248150A1 (en) Exosome containing exogenous antigen through gene transfection and method for utilizing the same
AU2002368056A1 (en) Novel pla2 enzyme, it's antibody, enzyme inhibitor and use and the preparation methods thereof
AU2003209648A1 (en) Subunits of the adenovirus fiber protein and uses thereof as vaccines
AU2043201A (en) Compositions and methods for regulating tumor-associated antigen expression
AU2003266585A1 (en) Novel mammal-origin protein negatively regulating the expression of antigen presentation-associated molecule such as b7-2 molecule or mhc class ii molecule on cell surface and utilization of the same
AU2003276844A1 (en) Formulations of modified antibodies and methods of making the same
AU2003239891A1 (en) Primer composition and bonded structure
AU2002351194A1 (en) Cell adhesion and extracellular matrix proteins
WO2004081030A8 (en) Peptides selectively lethal to malignant and transformed mammalian cells
AU2002321440A1 (en) Expression of modified antibodies in avian cells
AU2003262744A1 (en) Alpha-AMYLASE ASSAY AND USES THEREOF
AU2003295824A1 (en) Cell adhesion and extracellular matrix proteins
AU2003235096A1 (en) Novel protein and dna thereof
AU2003235252A1 (en) Yeast-origin promoter and vector and expression system using the same
AU2003265431A1 (en) Cell adhesion and extracellular matrix proteins
AU2003280992A1 (en) Novel proteins and use thereof
AU2002308567A1 (en) Cell adhesion and extracellular matrix proteins
AU2003228872A1 (en) Cell adhesion and extracellular matrix proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase